GlassScriptPhysician profile
David W Neckman
NPI 1801138615
$9,358.80
in general payments reported to CMS, 2019-2025
42 companies · $1,577 in 2025
The $1,577 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,488 · 2020: $1,498 · 2021: $853 · 2022: $1,674 · 2023: $1,047 · 2024: $1,222 · 2025: $1,577.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,911 · Travel and Lodging: $935.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,910.72 |
| Travel and Lodging | $934.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,273.33 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16, General - Pain Management |
| Abbott Laboratories | $1,508.18 | 2019-2025 | Eterna, Proclaim, Prodigy |
| Relievant Medsystems, INC. | $1,091.79 | 2022-2023 | Intracept |
| Collegium Pharmaceutical, INC. | $723.63 | 2019-2025 | Xtampza, Belbuca |
| Nevro Corp. | $538.25 | 2022-2024 | Senza |
| Forte Bio-Pharma LLC | $335.57 | 2020-2025 | Prolate, Nalocet, Tanlor |
| Saluda Medical Americas, INC. | $288.51 | 2024 | Evoke |
| Stryker Corporation | $172.01 | 2024 | Mild Device Kit |
| Biotronik Nro, INC. | $153.57 | 2024-2025 | Prospera |
| Pfizer INC. | $125.25 | 2019-2021 | |
| Stimwave Technologies Incorporated | $104.32 | 2021 | |
| Horizon Therapeutics Plc | $80.29 | 2019-2022 | |
| Pacira Therapeutics, INC. | $73.12 | 2019 | |
| Acelrx Pharmaceuticals, INC. | $72.63 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $71.94 | 2020-2021 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Neckman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.